See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: April 22 2005

Healthy Women Studies Epilepsy Acute Myelogenous Leukemia (AML)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

Healthy Women Studies

Researchers at the University of Kentucky Chandler Medical Center Orofacial Pain Center are conducting a clinical research study to examine physiological and emotional characteristics in people with and without orofacial pain. Research site located in Lexington, Ky.

More Information

Please see http://www.centerwatch.com/patient/studies/cat438.html.

-----

Epilepsy

This research study will compare mood changes among patients taking two FDA-approved drugs for partial seizures. This is a Phase 4 clinical research study, lasting 20 weeks, for participants at least 16 years of age who have had at least two partial or complex partial seizures in the previous six months. Research site located in Mineola, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat62.html.

-----

Acute Myelogenous Leukemia (AML)

A research study involving combination standard chemotherapy combined with a study drug for people with refractory or relapsed acute myelogenous leukemia (AML). Research site located in Manhasset, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat660.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.